Charles River Laboratories International (CRL) Receivables (2009 - 2025)

Charles River Laboratories International's Receivables history runs 17 years deep, the most recent figure standing at $719.3 million for Q4 2025.

• In Q4 2025, Receivables changed 0.22% year-over-year to $719.3 million; the TTM figure through Dec 2025 stood at $719.3 million (changed 0.22% YoY), while the FY2025 annual figure was $719.3 million, changed 0.22% from the prior year.
• Receivables was $719.3 million for Q4 2025 at Charles River Laboratories International, down from $748.3 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $818.7 million in Q3 2023 to a low of $610.6 million in Q1 2021.
• Historically, Receivables has averaged $742.4 million across 5 years, with a median of $755.4 million in 2024.
• The sharpest annual moves came in 2021 and 2024: Receivables advanced 22.35% in 2021, then fell 10.57% in 2024.
• A 5-year view of Receivables shows it stood at $657.6 million in 2021, then increased by 14.42% to $752.4 million in 2022, then grew by 7.14% to $806.1 million in 2023, then dropped by 10.57% to $720.9 million in 2024, then decreased by 0.22% to $719.3 million in 2025.
• The last three Receivables figures came in at $719.3 million (Q4 2025), $748.3 million (Q3 2025), and $780.4 million (Q2 2025), per Business Quant data.